Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Solberg, D. K.
Bentsen, H.
Refsum, H.
and
Andreassen, O. A.
2015.
Association between serum lipids and membrane fatty acids and clinical characteristics in patients with schizophrenia.
Acta Psychiatrica Scandinavica,
Vol. 132,
Issue. 4,
p.
293.
Melka, Melkaye G.
Castellani, Christina A.
O’Reilly, Richard
and
Singh, Shiva M.
2015.
Insights into the origin of DNA methylation differences between monozygotic twins discordant for schizophrenia.
Journal of Molecular Psychiatry,
Vol. 3,
Issue. 1,
Garcia-Alvarez, Leticia
Garcia-Portilla, Maria Paz
Gonzalez-Blanco, Leticia
Saiz Martinez, Pilar Alejandra
de la Fuente-Tomas, Lorena
Menendez-Miranda, Isabel
Iglesias, Celso
and
Bobes, Julio
2016.
Differential blood-based biomarkers of psychopathological dimensions of schizophrenia.
Revista de Psiquiatría y Salud Mental (English Edition),
Vol. 9,
Issue. 4,
p.
219.
Garcia-Alvarez, Leticia
Garcia-Portilla, Maria Paz
Gonzalez-Blanco, Leticia
Saiz Martinez, Pilar Alejandra
de la Fuente-Tomas, Lorena
Menendez-Miranda, Isabel
Iglesias, Celso
and
Bobes, Julio
2016.
Biomarcadores sanguíneos diferenciales de las dimensiones psicopatológicas de la esquizofrenia.
Revista de Psiquiatría y Salud Mental,
Vol. 9,
Issue. 4,
p.
219.
Perry, Benjamin I.
Salimkumar, Dhanya
Green, Daniel
Meakin, Anne
Gibson, Andrew
Mahajan, Deepali
Tahir, Tayyeb
and
Singh, Swaran P.
2017.
Associated illness severity in schizophrenia and diabetes mellitus: A systematic review.
Psychiatry Research,
Vol. 256,
Issue. ,
p.
102.
Garcia-Rizo, C.
Fernandez-Egea, E.
Oliveira, C.
Meseguer, A.
Cabrera, B.
Mezquida, G.
Bioque, M.
Penades, R.
Parellada, E.
Bernardo, M.
and
Kirkpatrick, B.
2017.
Metabolic syndrome or glucose challenge in first episode of psychosis?.
European Psychiatry,
Vol. 41,
Issue. 1,
p.
42.
Gjerde, Priyanthi B.
Dieset, Ingrid
Simonsen, Carmen
Hoseth, Eva Z.
Iversen, Trude
Lagerberg, Trine V.
Lyngstad, Siv Hege
Mørch, Ragni H.
Skrede, Silje
Andreassen, Ole A.
Melle, Ingrid
and
Steen, Vidar M.
2018.
Increase in serum HDL level is associated with less negative symptoms after one year of antipsychotic treatment in first-episode psychosis.
Schizophrenia Research,
Vol. 197,
Issue. ,
p.
253.
Sugawara, Norio
Maruo, Kazushi
Sugai, Takuro
Suzuki, Yutaro
Ozeki, Yuji
Shimoda, Kazutaka
Someya, Toshiyuki
and
Yasui-Furukori, Norio
2018.
Prevalence of underweight in patients with schizophrenia: A meta-analysis.
Schizophrenia Research,
Vol. 195,
Issue. ,
p.
67.
Lin, Yi-Chun
Lai, Chien-Liang
and
Chan, Hung-Yu
2018.
The association between rehabilitation programs and metabolic syndrome in chronic inpatients with schizophrenia.
Psychiatry Research,
Vol. 260,
Issue. ,
p.
227.
Mezquida, G.
Savulich, G.
Garcia-Rizo, C.
Garcia-Portilla, M.P.
Toll, A.
Garcia-Alvarez, L.
Bobes, J.
Mané, A.
Bernardo, M.
and
Fernandez-Egea, E.
2018.
Inverse association between negative symptoms and body mass index in chronic schizophrenia.
Schizophrenia Research,
Vol. 192,
Issue. ,
p.
69.
Soontornniyomkij, Virawudh
Lee, Ellen E.
Jin, Hua
Martin, Averria Sirkin
Daly, Rebecca E.
Liu, Jinyuan
Tu, Xin M.
Eyler, Lisa Todd
and
Jeste, Dilip V.
2019.
Clinical Correlates of Insulin Resistance in Chronic Schizophrenia: Relationship to Negative Symptoms.
Frontiers in Psychiatry,
Vol. 10,
Issue. ,
Kim, David D.
Barr, Alasdair M.
Fredrikson, Diane H.
Honer, William G.
and
Procyshyn, Ric M.
2019.
Association between Serum Lipids and Antipsychotic Response in Schizophrenia.
Current Neuropharmacology,
Vol. 17,
Issue. 9,
p.
852.
Luckhoff, H.
Phahladira, L.
Scheffler, F.
Asmal, L.
du Plessis, S.
Chiliza, B.
Kilian, S.
and
Emsley, R.
2019.
Weight gain and metabolic change as predictors of symptom improvement in first-episode schizophrenia spectrum disorder patients treated over 12 months.
Schizophrenia Research,
Vol. 206,
Issue. ,
p.
171.
Nadalin, Sergej
Jonovska, Suzana
Šendula Jengić, Vesna
and
Buretić-Tomljanović, Alena
2020.
An association between niacin skin flush response and plasma triglyceride levels in patients with schizophrenia.
Prostaglandins, Leukotrienes and Essential Fatty Acids,
Vol. 155,
Issue. ,
p.
102084.
Wang, Juan
Zhang, Yulong
Liu, Zhiwei
Yang, Yating
Zhong, Yi
Ning, Xiaoshuai
Zhang, Yelei
Zhao, Tongtong
Xia, Lei
Geng, Feng
Tao, Rui
Fan, Mei
Ren, Zhenhua
and
Liu, Huanzhong
2020.
Schizophrenia patients with a metabolically abnormal obese phenotype have milder negative symptoms.
BMC Psychiatry,
Vol. 20,
Issue. 1,
Gjerde, Priyanthi B.
Simonsen, Carmen E.
Lagerberg, Trine V.
Steen, Nils Eiel
Andreassen, Ole A.
Steen, Vidar M.
and
Melle, Ingrid
2021.
Sex-Specific Effect of Serum Lipids and Body Mass Index on Psychotic Symptoms, a Cross-Sectional Study of First-Episode Psychosis Patients.
Frontiers in Psychiatry,
Vol. 12,
Issue. ,
Wójciak, Paweł
Domowicz, Klaudia
and
Rybakowski, Janusz K.
2021.
Metabolic indices in schizophrenia: Association of negative symptoms with higher HDL cholesterol in female patients.
The World Journal of Biological Psychiatry,
Vol. 22,
Issue. 7,
p.
552.
Chen, Siwei
Lee, Justine
Truong, Tri Minh
Alhassen, Sammy
Baldi, Pierre
and
Alachkar, Amal
2021.
Age-Related Neurometabolomic Signature of Mouse Brain.
ACS Chemical Neuroscience,
Vol. 12,
Issue. 15,
p.
2887.
Wang, Juan
Zhang, Yulong
Yang, Yating
Liu, Zhiwei
Xia, Lei
Li, Wenzheng
Li, Zhongxiang
Xie, Xinhui
Deng, Wenfeng
Zhang, Kai
and
Liu, Huanzhong
2021.
The prevalence and independent influencing factors of obesity and underweight in patients with schizophrenia: a multicentre cross-sectional study.
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity,
Vol. 26,
Issue. 5,
p.
1365.
Kalinowska, Sylwia
Trześniowska-Drukała, Beata
Kłoda, Karolina
Safranow, Krzysztof
Misiak, Błażej
Cyran, Agnieszka
and
Samochowiec, Jerzy
2021.
The Association between Lifestyle Choices and Schizophrenia Symptoms.
Journal of Clinical Medicine,
Vol. 10,
Issue. 1,
p.
165.
Comments
No Comments have been published for this article.